Hill-Rom Holdings, Inc. (HRC) Receives Consensus Rating of “Hold” from Analysts

Shares of Hill-Rom Holdings, Inc. (NYSE:HRC) have earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $94.29.

Several equities research analysts have commented on HRC shares. Zacks Investment Research cut shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Tuesday, March 6th. ValuEngine raised shares of Hill-Rom from a “hold” rating to a “buy” rating in a report on Friday, March 2nd. Goldman Sachs Group started coverage on shares of Hill-Rom in a report on Wednesday, April 4th. They issued a “neutral” rating and a $85.00 target price on the stock. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $106.00 target price (up from $105.00) on shares of Hill-Rom in a report on Monday, April 30th.

In other news, SVP Deborah Rasin sold 7,590 shares of the company’s stock in a transaction dated Thursday, April 12th. The shares were sold at an average price of $86.02, for a total value of $652,891.80. Following the sale, the senior vice president now directly owns 14,028 shares of the company’s stock, valued at approximately $1,206,688.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Paul Sherwood Johnson sold 5,168 shares of the company’s stock in a transaction dated Friday, May 25th. The shares were sold at an average price of $90.88, for a total transaction of $469,667.84. Following the completion of the sale, the senior vice president now directly owns 4,063 shares in the company, valued at $369,245.44. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 29,570 shares of company stock worth $2,697,844. 1.90% of the stock is owned by insiders.

Several hedge funds have recently modified their holdings of HRC. Three Peaks Capital Management LLC acquired a new position in Hill-Rom in the 1st quarter valued at about $111,000. Point72 Asia Hong Kong Ltd grew its stake in Hill-Rom by 1,978.1% in the 1st quarter. Point72 Asia Hong Kong Ltd now owns 1,330 shares of the medical technology company’s stock valued at $116,000 after buying an additional 1,266 shares during the last quarter. We Are One Seven LLC acquired a new position in Hill-Rom in the 4th quarter valued at about $188,000. Campbell & CO Investment Adviser LLC acquired a new position in Hill-Rom in the 1st quarter valued at about $203,000. Finally, BancorpSouth Bank acquired a new position in Hill-Rom in the 4th quarter valued at about $241,000. 81.14% of the stock is currently owned by institutional investors.

NYSE:HRC traded down $0.11 on Friday, hitting $89.78. 560,100 shares of the company’s stock were exchanged, compared to its average volume of 461,549. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.85 and a quick ratio of 1.36. Hill-Rom has a 52 week low of $71.91 and a 52 week high of $94.63. The stock has a market capitalization of $6.00 billion, a PE ratio of 23.26, a price-to-earnings-growth ratio of 1.41 and a beta of 0.99.

Hill-Rom (NYSE:HRC) last issued its quarterly earnings results on Friday, April 27th. The medical technology company reported $1.05 EPS for the quarter, topping the consensus estimate of $1.02 by $0.03. Hill-Rom had a net margin of 6.85% and a return on equity of 20.18%. The firm had revenue of $710.50 million for the quarter, compared to analysts’ expectations of $707.54 million. During the same period in the previous year, the firm posted $0.88 EPS. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. analysts anticipate that Hill-Rom will post 4.63 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 29th. Stockholders of record on Friday, June 22nd will be issued a $0.20 dividend. The ex-dividend date is Thursday, June 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.89%. Hill-Rom’s payout ratio is 20.73%.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Analyst Recommendations for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply